GGHCX Mutual Fund

NAV$40.44

Fund Essentials - as of Mar 31, 2026

Net Assets
$681M
Expense Ratio
1.07%
Dividend Yield (Current)
5.48%
Holdings
81
Inception Date
Aug 7, 1989
Fund Family
Invesco (US)
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+3.53%
1 Year+16.17%
3 Year+7.69%
5 Year+7.40%
10 Year+11.40%

Asset Allocation

Stocks: 95.79%
Cash: 4.21%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly And Company9.07%
JNJJOHNSON AND JOHNSON5.81%
AZN:LNAstrazeneca Plc Adr4.34%
GILDGilead Sciences Inc4.10%
ABBVAbbvie Inc Health Care3.67%
Top 10 Concentration: 42.62%Report Date: Mar 31, 2026
Download all 81 holdings for GGHCX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
5.48%
Frequency
Annually
Latest Distribution
$9.93
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how GGHCX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$99/yr
7-day refund. Cancel anytime.
X-ray my whole portfolio
$99/yr Pro · 7-day refund. From MarketXLS, trusted since 2014.

GGHCX Mutual Fund Overview

GGHCX Mutual Fund (Invesco Health Care Fund Class A) is managed by Invesco (US) with $681.2M in net assets. GGHCX expense ratio is 1.07%, holding 81 positions across sectors including Health Care, Unknown, Real Estate. Inception date: 1989-08-07.

GGHCX performance shows a YTD return of 3.53%. The 1-year return is 16.17% and the 5-year return is 7.40%. GGHCX dividend yield stands at 5.48%, paid annually.

GGHCX top holdings include Eli Lilly And Company (9.1%), JOHNSON AND JOHNSON (5.8%), Astrazeneca Plc Adr (4.3%), Gilead Sciences Inc (4.1%), Abbvie Inc Health Care (3.7%). View all GGHCX holdings, sector breakdown, or dividend history.

GGHCX can be compared against other funds using the overlap calculator or side-by-side comparison tool. GGHCX alternatives are available via the screener, along with tax-loss harvesting opportunities.